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ABSTRACT
Single nucleotide polymorphisms (SNPs) are often
determined using TaqMan real-time PCR assays
(Applied Biosystems) and commercial software
that assigns genotypes based on reporter probe
signals at the end of amplification. Limitations to
the large-scale application of this approach include
theneedforpositivecontrolsoroperatorintervention
to set signal thresholds when one allele is rare. In
the interest of optimizing real-time PCR genotyping,
we developed an algorithm for automatic genotype
calling based on the full course of real-time PCR
data. Best cycle genotyping algorithm (BCGA),
written in the open source language R, is based on
the assumptions that classification depends on the
time (cycle) of amplification and that it is possible
to identify a best discriminating cycle for each SNP
assay. The algorithm is unique in that it classifies
samples according to the behavior of blanks (no
DNA samples), which cluster with heterozygous
samples. This method of classification eliminates
the need for positive controls and permits accurate
genotyping even in the absence of a genotype
class, for example when one allele is rare. Here, we
describe the algorithm and test its validity, com-
pared to the standard end-point method and to DNA
sequencing.
INTRODUCTION
The most common type of genetic diversity in the human
genome is the single nucleotide polymorphism (SNP),
which accounts for >90% of all sequence polymorphisms
(1,2). SNPs have revolutionized human molecular genetics
by providing a dense panel of genetic markers distributed
across the entire genome. Although most SNPs do not affect
gene function, they can be used to study population dynamics
and evolution, to investigate the genetic basis of complex
phenotypes and to develop diagnostic assays.
A number of techniques are now available for rapid SNP
genotyping. Akey requirement ofa SNP genotyping method is
that it distinguishes unequivocally between the allelic variants
present in homozygous and heterozygous forms. The choice of
technology depends on whether a few SNPs are to be screened
in many individuals or many different SNPs are to be
examined in a few individuals (3,4). Miniaturized assays,
such as microarrays with oligonucleotide reagents immobil-
ized on small surfaces, are frequently proposed for large-scale
mutation analysis and high-throughput genotyping (5). Other
high-throughput methods discriminate alleles by differential
hybridization, primer extension, ligation and cleavage of an
allele-speciﬁc probe (6,7).
A promising approach for a fully automated, large-scale
SNP analysis is the ‘homogeneous’ assay, i.e. a single-phase
assay without separation steps, permitting continual monitor-
ing during ampliﬁcation. The TaqMan assay (Applied Bio-
systems), originally designed for quantitative real-time
PCR, is a homogeneous, single-step assay also used in
determination of mutation status of DNA. The TaqMan
SNP Genotyping Assay exploits the 50-exonuclease activity
of AmpliTaq Gold DNA polymerase to cleave a doubly
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doi:10.1093/nar/gkl185labeled probe hybridized to the SNP-containing sequence of
ssDNA (1,8). Cleavage separates a 50-ﬂuorophore from a 30-
quencher (9) leading to detectable ﬂuorescent signal. The use
of two allele-speciﬁc probes carrying different ﬂuorophores
permits SNP determination in the same tube without any
post-PCR processing. Genotype is determined from the
ratio of intensities of the two ﬂuorescent probes at the end
of ampliﬁcation. Thus, rather than taking advantage of the full
set of real-time PCR data as in quantitative studies, only end-
point data are used.
TaqMan SNP genotyping in a high-throughput, automated
manner is facilitated by the use of validated Pre-made
TaqMan  Genotyping assays, but Custom TaqMan  Assays
may also be used (10,11). The results of the assay can be
automatically determined by genotyping software provided
with real-time thermal cyclers (e.g. IQ software of Bio-Rad,
Sequence Detection Software of Applied Biosystems). Since
these programs use autoscaling for generating the allele dis-
criminating plot, caution must be taken when analyzing data
for rare alleles. Therefore, accurate allele-calling requires
manual intervention of an expert operator who must assess
data quality, set ﬂuorescent signal thresholds and decide the
genotype. To avoid this problem, positive controls should be
included for all genotypes (12). In alternative to analyzing
end-pointﬂuorescentdatausingcommercialsoftwareorvisual
discrimination, a statistical clustering method called k-means
can be used (10).
In the interest of optimizing real-time PCR genotyping, we
have been investigating novel methods to analyze the ﬂuor-
escent signals. In particular, we looked for data clustering
algorithms to analyze the entire real-time PCR dataset, as
well as statistical approaches to analyze these data clusters.
Complexstatisticalmethods have alreadybeen usedtoanalyze
large datasets from genotyping experiments. For example, Liu
et al. (13) described the use of modiﬁed partitioning around
medoids (MPAM) clustering algorithm to analyze high-
density microarray data on SNPs, and Lovmar et al. (14)
reported that tag-array minisequencing microarray data
clusters can be distinguished on the basis of silhouette
score. Here, we describe an algorithm for automatic genotype
calling based on real-time PCR data and test its validity,
compared to the standard end-point method and to DNA
sequence data.
MATERIALS AND METHODS
Peripheral blood was obtained from healthy blood donors
(Sacco Hospital, Milan, Italy). Genomic DNA was extracted
using QIAmp DNA Blood Mini Kit (Qiagen, Milan,
Italy). DNA concentration was measured by absorbance at
260 nm using an ND-1000 spectrophotometer (NanoDrop
Technologies, Wilmington, DE, USA).
Real-time PCR SNP genotyping
Samples of genomic DNA were genotyped for 13 SNPs in
12 genes of major medical interest (Table 1). Genotyping was
performed using Custom TaqMan  Assays for 5 SNPs and
commercially available Pre-made TaqMan  Genotyping
assays for 8 SNPs. For custom assays, File Builder software
was used to select PCR primers and reporter probes labeled
with a quencher, a minor groove binder (MGB) and either
Table 1. SNPs employed to test the BCGA using TaqMan real-time PCR
Polymorphism dbSNP ID Location Chromosome Chromosome
position (bp)
Allele Allelic
frequency
ApoE  219 rs405509 Promoter 19 50100676 T 0.51
G 0.49
IL-1 alpha  889 rs1800587 Promoter 2 113259191 C 0.70
T 0.30
IL-1 beta  511 rs16944 Promoter 2 113311098 G 0.53
A 0.47
IL-6  174 rs1800795 Promoter 7 22539885 G 0.77
C 0.23
TNF alpha  238 rs361525 Promoter 6 31651080 G 0.92
A 0.08
TNF alpha  308 rs1800629 Promoter 6 31651010 G 0.91
A 0.09
IFN-g rs2069727 (30-UTR) 12 66834490 A 0.68
G 0.32
CST3 rs2424574 Intron 20 23556980 C 0.51
T 0.49
CACNA1D rs723540 Intron 3 53730993 G 0.60
C 0.40
AHRGEF3
a rs1500711 Intergenic region 3 56889194 T 0.66
C 0.34
SERPINA3 rs4934 Coding region 14 94150556 G 0.54
A 0.46
TF rs3811656 Coding region 3 134957026 G 0.70
A 0.30
LRRC2 rs1402152 Intron 3 46549422 T 0.67
C 0.33
Data are from dbSNP database (http://www.ncbi.nih.gov/SNP).
aSince this SNP is intergenic, the closest gene in indicated.
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propriety dye with lex ¼ 488 nm, lem ¼ 552 nm); these
sequences are reported in Supplementary Table 1. The
speciﬁc Pre-made TaqMan  Genotyping assays used in this
study were: tumor necrosis factor (TNF) alpha  238
(Applied Biosystems code C___2215707_10), IFN-g
(C___2683475_10), CST3 (C___9714066_10), CACNA1D
(C___1692260_10), AHRGEF3 (C___1482133_1),
SERPINA3 (C___2188895_10), TF (C___80379_10) and
LRRC2 (C___115203_10).
Real-time TaqMan PCR was performed according to the
manufacturer’s standard PCR protocol. Brieﬂy, 10 ng total
DNA was mixed with the supplied 2· TaqMan Universal
PCR Master Mix No AmpErase UNG and TaqMan Assay
Mix to a ﬁnal volume of 25 ml. Each sample underwent
45 ampliﬁcation cycles on an iCycler real-time thermal cycler
(Bio-Rad Laboratories, Hercules, CA). Fluorescent signals of
the two probes were monitored throughout the entire ampli-
ﬁcation using iCycler IQ software (Bio-Rad). For the ﬁrst
6 SNPs listed in Table 1, we tested a set of 32 samples and
2–3 blanks (no DNA); for each of the remaining 7 SNPs, we
tested 12–48 different samples and one blank.
Allelic calls were ﬁrst determined semi-automatically with
the aid of IQ software. Brieﬂy, the plots of ﬂuorescent inten-
sities per cycle for each reporter ﬂuorophore were visually
inspected to choose a baseline level, which was subtracted
from each data point. The end-point of each normalized
dataset was deﬁned as cycle number 40, as suggested by
the manufacturer. End-point ﬂuorescent intensities of each
probe were plotted in an allelic discrimination graph (VIC
on abscissa, FAM on ordinate), and genomic ‘clusters’
were deﬁned manually by sectioning the plots into quadrants
with horizontal and vertical lines.
Best cycle genotyping algorithm (BCGA)
Genotype calling from real-time PCR data were performed
using an algorithm, called BCGA, written in the open source
language R (R Foundation for Statistical Computing, Vienna,
Austria). BCGA is composed of ﬁve main steps (Figure 1):
(i) Selection of best cycle. The genotype analysis is based on
the hypothesis that, during amplification, one cycle is
most discriminating, not necessarily the end-point.
Thus, we calculated the differences in probe intensities
(VIC-FAM) at every cycle, and chose the cycle that had
the greatest variance in intensity differences among sam-
ples (best cycle).
(ii) Data clustering. Working with data from the best cycle
chosen in step 1, samples were grouped into clusters
based on the fluorescent signal differences. This classi-
fication procedure was performed using partitioning
around medoids (PAM) algorithm (15), which is included
in the R Cluster Package. For SNP genotyping, 1–3 clus-
ters are expected.
(iii) Choice of best clustering model. The best number of
clusters for a particular SNP dataset, including the blanks,
was chosen on the basis of average silhouette width (16),
determined using R Cluster Package. Silhouette width,
s(i), is defined as the average dissimilarity between a
sample and all other specimens of its class, compared
to all observations in the neighboring clusters. The
best number of clusters is determined on the basis of
the highest average silhouette width.
(iv) Genotype calling. Assignment of generic genotypes (AA,
AB, BB) takes into consideration the behavior of blanks
during the PCR time course. We observed that the dif-
ference in fluorescent signal (VIC-FAM) over time was
relatively stable and near zero for blanks as well as for
known heterozygotes. Thus, the algorithm identifies the
heterozygous cluster as the one containing the blanks.
Homozygous clusters are then defined on the basis of
the predominance of one or the other fluorescent signal.
This classification procedure, based on the behavior of
blanks, can be used when one genotype class is absent
from a set of samples, for example when one allele is
rare. In principle, the method can also be applied in the
presence of a unique homozygous genotype (e.g. a single
cluster distinct from the one formed by blanks).
(v) Quality control. The quality of assignment of individual
samples to clusters was determined on the basis of silhou-
ette values (16). Individual samples with a large s(i), i.e.
close to 1, are well clustered, with a small s(i) lie between
two clusters, and with a negative s(i) are misclassified.
Furthermore, the quality of the genotype assignments to
clusters was determined from the average silhouette
width over all samples: the larger the silhouette width,
the higher quality the PAM classification.
The BCGA code and a help ﬁle are publicly available
at http://www.dpci.unipd.it/Bioeng/Publications/BCGA.htm.
Moreover, this page provides access to seven datasets that
may be used to test the algorithm and the corresponding results
in graphic format.
Validation of BCGA
BCGA genotype calls were validated by DNA sequencing of
PCR-ampliﬁed DNA for the ﬁrst 6 SNPs listed in Table 1.
Sequencing was not considered necessary for the remaining
seven validated Pre-made TaqMan  Genotyping assays; in
these cases, we considered the genotype calls of the standard
end-point procedure to be the reference value.
In the validation study, we determined the actual allelic
compositions of 14 samples chosen on the basis of BCGA
genotype calls in order to maximize the chances of having
all alleles represented in 6 SNPs genotyping assays. To this
end, we designed PCR primer sets to amplify the DNA
containing 6 SNPs (Supplementary Table 2). For TNF
alpha, the PCR primers permitted sequence validation also
of the SNP at position  238, assayed with a Pre-made
TaqMan  Genotyping assay. Forward and reverse primers
were synthesized by Thermo Hybaid (Ulm, Germany). PCR
was conducted in a ﬁnal volume of 12.5 ml containing 200 ng
genomic DNA, 1· PCR buffer, 1.2 mM dNTPs, 20 pmol each
primer (one reaction per primer set) and 0.2 U Platinum Taq
DNA Polymerase High Fidelity (Invitrogen, Carlsbad, CA).
After an initial denaturation step at 95 C, ampliﬁcation was
carried out in 35 cycles consisting of 30 s at 94 C, 1 min at
55 C and 1 min at 68 C. A ﬁnal, 7 min extension at 68 C
ended each reaction.
Quality of PCR products was assessed by microcapillary
electrophoresis (2100 Bioanalyzer, Agilent Technologies,
Palo Alto, CA). PCR products were puriﬁed using the ExoSAP
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Uppsala, Sweden) and sequenced with the DYEnamic
ET Dye Terminator Kit (GE Healthcare) according to the
manufacturer’s instructions. Sequencing runs were performed
on the MegaBACE 100 DNA Analysis System (GE Health-
care) according to the manufacturer’s instructions, with injec-
tions at 3 kV for 40 s and sequencing runs at 6 kV for 180 min.
The run results were analyzed using Sequence Analyzer
software (GE Healthcare). Sequencing was carried out on
forward and reverse strands.
RESULTS
The genotypes of healthy blood donors, regarding 13 SNPs in
12 genes, were assessed by a standard analysis of TaqMan
end-point ﬂuorescent data and by a novel BCGA. At standard
end-point analysis of 32 subjects (Figure 2), clear identiﬁca-
tion of three tight clusters permitted easy assignment of
allele-1 (AA), allele-2 (BB) and heterozygous (AB) genotypes
for 3 SNPs: apolipoprotein E  219, interleukin (IL)-1 beta
 511 and IL-6  174. Only two clusters were observed for
TNF alpha  238, while one broad cluster was observed for
TNF alpha  308. In the analysis of IL-1 alpha  889, three
genotypeclusterswere identiﬁed,buttwosamples(samples 17
and 22) in the heterozygote quadrant showed unique behavi-
ors, casting doubts on the accuracy of the genotype assign-
ment. Similar patterns were observed for the seven other SNPs
studied (Supplementary Figure 1). These data exemplify the
difﬁculties encountered in end-point PCR analysis of SNPs,
precluding the use of automatic genotype calling software and
necessitating operator intervention.
Figure 1. Five major steps of the novel BCGA. PAM, partitioning around medoids.
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escent intensities of the two reporter probes at an arbitrarily
chosen PCR cycle near the end of ampliﬁcation (usually cycle
40), our algorithm considers the time course of ﬂuorescent
signals throughout the ampliﬁcation. Plots of FAM versus
VIC ﬂuorescent intensities (not baseline-subtracted) at each
ampliﬁcation cycle for 32 samples and 1–3 blanks (Figure 3)
show the unique time courses of the signals: the probes may be
easily distinguished at all time points, or their signals may ﬁrst
diverge and then converge toward the diagonal (e.g. TNF
alpha  308). Nonetheless, for this latter SNP, the temporal
tracespermitdistinctionofclustersatearliercycles.Ofthetwo
outlying samples seen at end-point analysis of IL-1 alpha
 889, BCGA assigned sample 22 to the allele-1 cluster and
sample 17 tothe heterozygous cluster,although the ﬂuorescent
trace of 17 remained distinct (Figure 3). In all cases, blank
samples (no DNA) had ﬂuorescent signals lower than that
of the ﬁrst cycles of experimental samples and showed no
relevanttimetrendinsignalduringampliﬁcation.Thus,blanks
are all located in the lower left-hand corner of each graph.
Similar results were observed for the remaining 7 SNPs
(Supplementary Figure 2).
In BCGA, samples are classiﬁed according to the differ-
ences in their reporter probe signals. During the course of PCR
(Figure 4 and Supplementary Figure 3), this difference for
blanks is relatively stable and near zero because there is no
probe degradation. This difference also remains near zero for
heterozygous samples because the two probes are degraded to
a similar extent. Therefore, classiﬁcation according to signal
differences places blanks and heterozygotes in the same
cluster, and permits BCGA to begin genotype calling by
identifying the heterozygous cluster as that containing the
blanks.
BCGA is based on the hypothesis that best allelic discrim-
ination is not necessarily at the end of PCR ampliﬁcation.
Thus, for each SNP analysis, we determined the PCR cycle
with the greatest variance in the difference between the two
ﬂuorescent probe signals (best cycle). The best cycle for
Figure 2. Allelic discrimination plots of end-point fluorescent TaqMan PCR data of 6 SNPs analyzed in 32 healthy blood donors. VIC fluorophore (x-axis) is
associated with the probe for allele A, while FAM (y-axis) labels the allele B probe. The plots were generated using iCycler IQ software (Bio-Rad, Hercules, CA).
For IL-1 alpha  889, outlying samples 17 and 22 are marked.
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conﬁrm our hypothesis that an arbitrarily chosen PCR cycle
(e.g. 40) is not necessarily the best for distinguishing TaqMan
reporter probe signals.
Using reporter probe signals at the best cycle, we employed
PAM to group the samples and blanks into 2 or 3 clusters.
The best classiﬁcation model was determined on basis of the
highest average silhouette width for all samples, including
blanks. The best classiﬁcation contained two clusters for
3 SNPs, while a three cluster model was chosen for
10 SNPs (Table 2). For IL-6  174, one cluster contained a
single sample. Average silhouette width ranged from 0.71
(AHRGEF3) to 0.93 (SERPINA3). Silhouette bar plots of
individual s(i) values illustrate the classiﬁcation of samples
and blanks into two or three clusters (Figure 5 and Supple-
mentary Figure 4); for the cluster containing only one sample,
calculation of silhouette width was mathematically not
possible.
To make the genotype calls, we ﬁrst identiﬁed the hetero-
zygous cluster as the one containing the blanks, given that
differences in reporter probe signals for heterozygotes are
comparable with those for blank samples, irrespective of
the actual signal intensities. When multiple blanks were
used, they were always assigned to the same cluster
(Figure 5). The genotype calls of the other 1–2 clusters per
SNP analysis were made on the basis of the predominating
reporter probe at the best PCR cycle. The number of samples
for each cluster (excluding blanks) and the speciﬁc genotype
Figure3.Real-timePCRtracesofVIC-andFAM-labeledreportedprobeintensitiesateachcycle,for6SNPsanalyzedin32subjects.Tracesarelabeledwithsample
numbers at the best cycle. Blank samples (B) are clustered at the lower left-hand corner of each plot (low fluorescent signal intensity without temporal changes).
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Supplementary Figure 4.
Quality of assignment of individual samples to clusters
was determined on the basis of silhouette values. Almost
all samples had s(i) > 0.65, indicating good classiﬁcation.
One exception was sample 17, in the analysis of IL-1 alpha
 889, which had s(i) ¼ 0.299; this sample was considered
an outlier at end-point analysis (Figure 2) and was visually
distinct from the heterozygous cluster in the plot of ﬂuorescent
traces (Figure 3). Poor classiﬁcation was also observed in
AHRGEF3 assay for four samples with s(i) values between
0.36 and 0.61 (Supplementary Figure 4). These samples did
not form tight clusters at end-point analysis (Supplementary
Figure1).Finally,forsample24inIL-6  174analysis,avalue
of s(i) could not be determined because it was the only sample
in its cluster.
The accuracy of genotype calls made by standard end-point
analysis and by BCGA was determined by direct sequencing
of PCR-ampliﬁed genomic DNA for 14 selected subjects and
for the ﬁrst 6 SNPs, including all 5 SNPs tested with Custom
TaqMan  assays. Overall, end-point analysis with operator
intervention correctly called 72 of 84 analyses (6 SNPs in
14 subjects), while BCGA correctly called all 84 analyses
(Table 3). Most errors during standard analysis regarded
TNF alpha  308. For the remaining 7 SNPs, there was
exact agreement in genotype call between end-point analysis
Figure 4. Real-time PCR traces of differences in reporter probe signals, for 6 SNPs analyzed in 32 subjects, demonstrate the co-segregation of blanks with
heterozygous samples. Traces for blank samples are shown in red.
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AHRGEF3 assay (data not shown).
DISCUSSION
BCGA permits accurate genotype calling by taking advantage
of the full course of real-time PCR data. BCGA is based on
the assumptions that classiﬁcation depends on the time (cycle)
of ampliﬁcation and that it is possible to identify a best
discriminating cycle for each SNP assay. The algorithm is
unique in that it classiﬁes data clusters according to the
behavior of blanks (no DNA samples), thereby eliminating
the need for positive controls and permitting accurate
genotyping even in the absence of a genotype class, for
example when one allele is rare. The method can also be
applied in the presence of a unique genotype, provided that
is not the heterozygous one. Finally, the algorithm works
Table 2. Best cycle, cluster number and average silhouette width for 13 SNPs
assayed with BCGA (including blanks)
Polymorphism Best cycle Clusters, n Average s(i)
ApoE  219 42 3 0.87
IL-1 alpha  889 38 3 0.83
IL-1 beta  511 43 3 0.89
IL-6  174 44 3 0.88
TNF alpha  238 36 2 0.89
TNF alpha  308 34 2 0.91
IFN-g 43 3 0.88
CST3 44 3 0.92
CACNA1D 44 2 0.91
AHRGEF3 44 3 0.71
SERPINA3 39 3 0.93
TF 44 3 0.91
LRRC2 44 3 0.91
Figure 5. Silhouettewidths(i)histogramsfor32samplesand2–3blanks(speckledbars),classifiedaccordingtopartitioningaroundmedoids(PAM)(13).Foreach
SNP analyzed, the plots report the number of samples, n, assigned to each generic genotype cluster (excluding blanks), and the mean silhouette width, S, for each
cluster.
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zation or background subtraction.
These characteristics of BCGA improve upon standard
methods of SNP determination with TaqMan assays, in
which semi-automated genotype assignments are based on
the ratio between the ﬂuorescent intensities of VIC and
FAM after normalization. A high VIC/FAM ratio represents
a homozygous allele-1 sample (cleaved VIC, intact FAM
probes) and vice versa a low VIC/FAM ratio corresponds
to a homozygous allele-2 sample; a ratio close to unity rep-
resents the heterozygotic state (17). This theoretical behavior
is observed with validated Pre-made TaqMan  Genotyping
assays, which are optimized in a multistep protocol including
the selection of probes and primers lacking homology to other
sequences in the human genome (11). To study SNPs for
which validated assays are not available, ad hoc Custom
TaqMan  assays may be requested, as we did in the present
study. In these cases, even though the best probes and primers
had been selected using the manufacturer’s proprietary algo-
rithm, it is possible to observe atypical behavior of a few
samples (e.g. the outliers in IL-1 alpha  889) or of the entire
population (e.g. TNF alpha  308). This non-classic behavior
makes it difﬁcult to establish universal thresholds for genotype
assignments. Thus, to obtain valid information using the cur-
rent end-point data analysis, it is necessary to optimize the
structure of the allele discriminating probes (18,19) or to
develop speciﬁc genotyping methods (20). However, the
need for individual assay optimization hinders large-scale
SNP screening, which requires universal methods and tools
(3). A computational method like BCGA that lets investigators
obtain accurate genotype information from Custom TaqMan 
assays, even in light of the unique and sometimes problematic
behavior of SNPs, represents a useful contribution to auto-
matic SNP genotyping. A disadvantage of this approach using
the full course of real-time data rather than end-point data are
that a real-time PCR instrument is required rather than just a
ﬂuorescent reader.
Our hypothesis that during real-time PCR there is a best
cycle in which to analyze data were conﬁrmed by the traces of
VIC versus FAM ﬂuorescent intensities, which diverge up to
three distinct proﬁles starting at about PCR cycle 25 and then
tend to converge back towards the central, diagonal proﬁle at
later cycles. Whether the clusters reach the diagonal or simply
turn inward depends on the number of PCR cycles performed
and on characteristics of the individual SNPs. This behavior is
explained by the release of both ﬂuorophores due to non-
speciﬁc degradation of both probes. Although standard ampli-
ﬁcation reactions are performed up to 35 cycles, the universal
thermal cycling protocol of TaqMan Genotyping Assays
recommends that real-time PCR be carried out to 45 cycles,
with end-point reading typically at cycle 40. In our study,
the best cycles were essentially the latest cycles before the
phenomenon of non-speciﬁc probe degradation raised the
signal-to-noise ratio; in the extreme case (TNF alpha
 308), probe degradation resulted in a non-interpretable,
single broad cluster at cycle 40. Selection of the best cycle
allowed us to obtain good genotyping data even from a
suboptimal assay.
BCGA is the ﬁrst method to assign genotypes based on
an analysis of the full course of TaqMan real-time data. An
algorithm reported by Ranade et al. (10) used end-point data to
assign samples to a predetermined number of groups; a quality
scorewas then calculatedfor each genotypeassuming abivari-
ate normal distribution of ﬂuorescent values. BCGA makes
use of PAM, a more robust version of k-means introduced by
Kaufman and Rousseeuw (15), to cluster samples at the best
discriminating cycle asdeterminedby theanalysisofthe entire
time course. Moreover, quality of PAM classiﬁcation is
assessed by the parameter silhouette width, developed for
this purpose by one of the authors of PAM (16). Quality
assessment according to silhouette width was also used by
Liu et al. (13) and Lovmar et al. (14) in the analysis of
microarray data. Both these groups observed that silhouette
widths above 0.65 corresponded to visually good classiﬁca-
tion, and Lovmar et al. (14) proposed a more conservative
cutoff of 0.7. Our use of silhouette to assess PAM classiﬁca-
tion is in agreement with these studies, because s(i) exceeded
0.65 for all analyses, with six exceptions. One sample in the
analysis of IL-1 alpha  889 gave s(i) ¼ 0.299, indicating poor
classiﬁcation; we attribute this low reading to experimental
error. For another sample in the analysis of IL-6, s(i) was
undetermined because it was the only sample in a cluster.
Finally, four samples in the assay of AHRGEF3 had low
s(i), possibly due to their anomalous, delayed signals during
the course of PCR.
The few poorly classiﬁed samples in our study illustrate
the advantages of using silhouette width, rather than visual
inspection of plots, in data quality control. Mathematical
evaluation of classiﬁcation quality facilitates the identiﬁcation
of samples that were not accurately assessed and thus need to
be retested, reducing the need for manual editing and the
chance of human error. Moreover, the use of mathematical
quality checking, as provided by silhouette width or proba-
bility score of k-means, may help identify samples with allelic
imbalance due to DNA duplications. Allelic balance must be
conﬁrmed by quantifying copy number of each allele using
other methods (21,22). A false suggestion of allelic imbalance
may come from differences in the maximum ﬂuorescent
intensities of the two ﬂuorophores upon release from reporter
probes, possibly due to differences in their chemical environ-
ments. We observed this behavior for LRRC2 Pre-made
TaqMan  Genotyping assays, for which the maximum
ﬂuorescent signal of one probe exceeded three times that of
the other probe (Supplementary Figure 5). In such cases, and
when at least two clusters are present, classiﬁcation based on
raw data may be incorrect and scaling is necessary. To handle
Table 3. Genotype determination of 6 SNPs in 14 subjects, by direct
sequencing of both strands, and comparison with results from end-point
fluorescent PCR analysis and the novel BCGA (real-time fluorescent PCR)
SNP Subjects, n Correct calls, n
AA AB BB End-point BCGA
ApoE  219 3 4 7 14 14
IL-1 alpha  889 7 5 2 13 14
IL-1 beta  511 5 5 4 14 14
IL-6  174 7 6 1
a 14 14
TNF alpha  238 0 2 12 14 14
TNF alpha  308 11 3 0 3 14
aThis subject corresponds to sample 24, the only BB homozygote found for
this SNP; thus despite an incalculable silhouette width, the genotype calls at
end-point and BCGA analysis were correct.
PAGE 9 OF 10 Nucleic Acids Research, 2006, Vol. 34, No. 7 e56this problem, BCGA performs a quality check on the ratio of
the probes’ maximum ﬂuorescent signals and ﬂags situations
where this ratio exceeds three; this permits the operator to
intervene by applying an optional scaling step, which should
be sufﬁcient for sample classiﬁcation. In this case, scaling
permitted excellent classiﬁcation—with s(i) > 0.8 for all
samples—and genotype calls were in exact agreement with
those of the standard method.
We believe that the BCGA is a valid computational method
for analyzing TaqMan real-time PCR data, because it provides
accurate genotype calls even for samples that exhibit atypical
behavior during standard TaqMan genotype assay. BCGA is
especially useful for SNP genotyping when the minor allele is
rare or absent, since the clustering step does not require the
presence of the three expected genotype classes. Moreover,
the ability of the algorithm to identify the best discriminating
cycle in which to assign genotypes overcomes the problematic
behavior of some SNPs observed with Custom TaqMan 
assays. Compared to currently available software, this
open source algorithm is a substantive and important impro-
vement in both the implementation and accuracy of SNP
discrimination.
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Supplementary data are available at NAR Online.
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